Organon is a healthcare company. It focuses on the health of women throughout their lives. Organon is based in JERSEY CITY, N.J.
| Revenue (Most Recent Fiscal Year) | $6.22B |
| Net Income (Most Recent Fiscal Year) | $187.00M |
| PE Ratio (Current Year Earnings Estimate) | 4.26 |
| PE Ratio (Trailing 12 Months) | 4.58 |
| PEG Ratio (Long Term Growth Estimate) | 1.27 |
| Price to Sales Ratio (Trailing 12 Months) | 0.59 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 3.58 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 2.37 |
| Pre-Tax Margin (Trailing 12 Months) | 8.01% |
| Net Margin (Trailing 12 Months) | 3.41% |
| Return on Equity (Trailing 12 Months) | 88.97% |
| Return on Assets (Trailing 12 Months) | 6.03% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.95 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.44 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 8.43 |
| Inventory Turnover (Trailing 12 Months) | 2.06 |
| Book Value per Share (Most Recent Fiscal Quarter) | $3.83 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.80 |
| Earnings per Share (Most Recent Fiscal Year) | $3.43 |
| Diluted Earnings per Share (Trailing 12 Months) | $0.77 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Common Shares Outstanding | 262.61M |
| Free Float | 258.36M |
| Market Capitalization | $3.61B |
| Average Volume (Last 20 Days) | 2.75M |
| Beta (Past 60 Months) | 1.55 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 1.62% |
| Percentage Held By Institutions (Latest 13F Reports) | 77.43% |
| Annual Dividend (Based on Last Quarter) | $0.08 |
| Dividend Yield (Based on Last Quarter) | 0.58% |